Wide-complex tachycardia: Difference between revisions

No edit summary
Line 7: Line 7:


==Treatment==
==Treatment==
#Pulseless: Unsynchronized cardioversion (defibrillation) 200J
*Pulseless: Unsynchronized cardioversion (defibrillation) 200J
#Unstable:
*Unstable:
##Regular: Synchronized cardioversion 100-200J
**Regular: Synchronized cardioversion 100-200J
##Irregular: Unsynchronized cardioversion (defibrillation) 200J
**Irregular: Unsynchronized cardioversion (defibrillation) 200J
#Stable
*Stable
##Regular (tx as presumed V-tach)
**Regular (tx as presumed V-tach)
###Procainamide (20mg/min)
***Procainamide (20mg/min)
###Amiodarone (150mg over 10min, then 1mg/min gtt x 6hrs)
***Amiodarone (150mg over 10min, then 1mg/min gtt x 6hrs)
####Agent of choice in setting of AMI or LV dysfunction
****Agent of choice in setting of AMI or LV dysfunction
###Lidocaine 1-1.5mg/kg IV q5min, repeat prn until up to 300mg/hr
***Lidocaine 1-1.5mg/kg IV q5min, repeat prn until up to 300mg/hr
##Irregular (tx as presumed preexcited [[A-fib]])
**Irregular (tx as presumed preexcited [[A-fib]])
###Procainamide (20mg/min)
***Procainamide (20mg/min)
###Amiodarone (150mg over 10min, then 1mg/min gtt x 6hrs)
***Amiodarone (150mg over 10min, then 1mg/min gtt x 6hrs)
###Sotalol (100 mg IV over 5 minutes)
***Sotalol (100 mg IV over 5 minutes)
###Mg 1-2gm IV over 60-90s, then infuse 1-2gm/hr (for [[Torsades De Pointes]])
***Mg 1-2gm IV over 60-90s, then infuse 1-2gm/hr (for [[Torsades De Pointes]])


==DDx Regular==
==DDx Regular==
#V-tach
*V-tach
#SVT w/ BBB (fixed or rate related)
*SVT w/ BBB (fixed or rate related)
#SVT w/ accessory pathway
*SVT w/ accessory pathway
#A flutter w/ BBB
*A flutter w/ BBB
#Sinus tachycardia with BBB (fixed or rate related)
*Sinus tachycardia with BBB (fixed or rate related)


==DDX Irregular==
==DDX Irregular==
#[[A-fib]]/flutter w/ variable AV conduction AND BBB (fixed or rate-related)
*[[A-fib]]/flutter w/ variable AV conduction AND BBB (fixed or rate-related)
#[[A-fib]]/flutter w/ variable AV conduction AND accessory pathway
*[[A-fib]]/flutter w/ variable AV conduction AND accessory pathway
#[[A-fib]] + [[Hyperkalemia]]
*[[A-fib]] + [[Hyperkalemia]]
#Polymorphic v-tach/torsades
*Polymorphic v-tach/torsades


==Disposition==
==Disposition==

Revision as of 04:17, 9 April 2015

Background

Diagnosis

Ventricular tachycardia

Treatment

  • Pulseless: Unsynchronized cardioversion (defibrillation) 200J
  • Unstable:
    • Regular: Synchronized cardioversion 100-200J
    • Irregular: Unsynchronized cardioversion (defibrillation) 200J
  • Stable
    • Regular (tx as presumed V-tach)
      • Procainamide (20mg/min)
      • Amiodarone (150mg over 10min, then 1mg/min gtt x 6hrs)
        • Agent of choice in setting of AMI or LV dysfunction
      • Lidocaine 1-1.5mg/kg IV q5min, repeat prn until up to 300mg/hr
    • Irregular (tx as presumed preexcited A-fib)
      • Procainamide (20mg/min)
      • Amiodarone (150mg over 10min, then 1mg/min gtt x 6hrs)
      • Sotalol (100 mg IV over 5 minutes)
      • Mg 1-2gm IV over 60-90s, then infuse 1-2gm/hr (for Torsades De Pointes)

DDx Regular

  • V-tach
  • SVT w/ BBB (fixed or rate related)
  • SVT w/ accessory pathway
  • A flutter w/ BBB
  • Sinus tachycardia with BBB (fixed or rate related)

DDX Irregular

  • A-fib/flutter w/ variable AV conduction AND BBB (fixed or rate-related)
  • A-fib/flutter w/ variable AV conduction AND accessory pathway
  • A-fib + Hyperkalemia
  • Polymorphic v-tach/torsades

Disposition

  • Admit all pts (even if converted to NSR with adenosine)

See Also

Source

  • Rosen's